← American Pharmacists Association (APhA)
FTCNonrulemakingFTC-2023-0043

Draft Merger Guidelines for Public Comment

RIN
—
Last modified
Sep 29, 2023
Comment window
closed 1044d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 19, 2023 and Sep 19, 2023. 70 other organizations filed here. The comment window closed 1044d ago.

What American Pharmacists Association (APhA) filed (1)

Sep 19, 2023· Comment from American Pharmacists Association· FTC-2023-0043-1503

The American Pharmacists Association is pleased to submit comments on the Federal Trade Commission's (FTC) and the Antitrust Division of the Department of Justice's (DOJ) draft update to the merger guidelines. APhA strongly supports FTC's and DOJ's update which is necessary to apply to real-world mergers and the harm to competition and choice in the pharmacy benefit manager (PBM) marketplace. APhA is the largest association of pharmacists in the United States advancing the entire pharmacy profession. APhA represents pharmacists in all practice settings, including community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. See, attached .PDF for full comments. APhA looks forward to continuing to work with the FTC and DOJ to return competition to the PBM and healthcare marketplace in order to protect our nation's community pharmacies, and our patients by promoting healthcare equity and access in our nation's rural and underserved communities.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (70)

See everyone who commented →
Draft Merger Guidelines for Public Comment (FTC) — American Pharmacists Association (APhA) | OpenPolis